Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My take on the timing of the PR

My apologies for a 'factor of 10' typo in the 10% calc - it should be about 41M, not 4.1M!!

To call a special Shareholder meeting needs 10% - i.e. representation of about 41 million shares. Can we get that level of support?

Share
New Message
Please login to post a reply